Results 151 to 160 of about 5,391 (252)

Impact of Hemoglobin Improvement on Survival in Patients With Myelofibrosis and Anemia Treated With Momelotinib in the SIMPLIFY‐1 and MOMENTUM Trials

European Journal of Haematology, Volume 117, Issue 5, Page 1265-1274, November 2026.
In this post hoc analysis of the phase 3 SIMPLIFY‐1 and MOMENTUM trials, the number of patients with baseline hemoglobin < 10 g/dL who achieved hemoglobin ≥ 10 g/dL by week 24 with momelotinib, as well as the time to achievement, were evaluated. Patients who were JAK inhibitor naive and/or had moderate anemia were more likely and faster to achieve this
Francesca Palandri, Casey O'Connell, Pankit Vachhani, Donal P. McLornan, Steffen Koschmieder, Juan Carlos Hernandez‐Boluda, Kazuya Shimoda, Shiyuan Zhang, Catherine Ellis, Jessica Lim, Jasmine Sahni, Vikas Gupta   +11 more
wiley   +1 more source

Sotatercept-related peripheral microvascular alterations in systemic sclerosis-associated pulmonary arterial hypertension: insights from nailfold capillaroscopy. [PDF]

Rheumatol Adv Pract
Segawa Y, Takahashi T, Yamamoto J, Segawa K, Takahashi T, Wada-Irimada M, Muto Y, Takahashi T, Kikuchi N, Yamamoto S, Sato H, Yaoita N, Satoh T, Yasuda S, Asano Y.   +14 more
europepmc   +1 more source

Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case–control study

Headache: The Journal of Head and Face Pain, Volume 66, Issue 10, Page 2337-2349, November/December 2026.
Abstract Objectives/Background Cluster headache (CH) has historically been considered a male‐dominated disorder, suggesting a role for androgens in its pathophysiology. We aimed to evaluate hormone profiles and symptoms of androgen deficiency in CH.
Willemijn C. Naber, Roemer B. Brandt, Mariël Leon Morales‐Grooters, Ronald van der Wal, Sjoerd A. A. van den Berg, Jelle J. Goeman, Antoinette Maassen van den Brink, Rolf Fronczek   +7 more
wiley   +1 more source

Lipoprotein(a), Endothelial Dysfunction and Cardiovascular Disease

Journal of Cellular and Molecular Medicine, Volume 30, Issue 21, November 2026.
ABSTRACT Lipoprotein(a) (Lp(a)) is a particle similar to low‐density lipoprotein cholesterol and is associated with apolipoprotein (A). High Lp(a) levels are a genetic, independent risk factor for atherosclerotic cardiovascular disease (ASCVD). Endothelial cells, which form the continuous lining of the cardiovascular system, are crucial for vascular ...
Xianghui Zhou, Xiyuan Fang, Xin Zhou, Zhao Zhang, Yu Hu, Zhipeng Cheng   +5 more
wiley   +1 more source

Integrative follicular fluid biomarkers for oocyte competence and IVF outcomes: from molecular networks to multianalyte panels. [PDF]

Front Endocrinol (Lausanne)
Chen CY, Lu YT, Chang PH, Chen HJ, Hsueh YW, Chang CW, Hsu HC, Yang TC, Chang YY, Chang HM.   +9 more
europepmc   +1 more source

Human Bone Morphogenetic Protein‐3 Mature Ligand Is Larger Than Recorded Indicating Earlier Publications Are Flawed

The FASEB Journal, Volume 40, Issue 20, 31 October 2026.
BMP‐3 is synthesized as a proprotein that is cleaved by furin/proprotein convertases (PC) to release the biologically active mature ligand. Although never experimentally verified, the BMP‐3 ligand is recorded as C‐terminal Q363‐R472 (110 amino acids) approximately 16 kDa.
David E. Phelan, Caitriona Scaife, Emma R. Dorris, John Russell, Madeline Murphy   +4 more
wiley   +1 more source

Activin Signaling Inhibitors in Pulmonary Hypertension: A State-of-the-Art Review. [PDF]

Pulm Circ
Rajagopal S, Abueg J, Hart KM, Lau E, Martinez EC, Morrell NW, Preston IR, Sahay S, Sood N, Yu PB, Zayas-Hernández NG.   +10 more
europepmc   +1 more source

NFкB pathway suppression as a key driver of pacritinib response in high‐risk myelofibrosis

British Journal of Haematology, Volume 209, Issue 5, Page 2331-2334, November 2026.
R. Van Dijck, M. ter Borg, B. van der Holt, A. E. C. Broers, M. D. Hazenberg, J. J. Cornelissen, N. P. M. Schaap, E. de Pater, P. A. W. te Boekhorst   +8 more
wiley   +1 more source

Disentangling Pulmonary Vascular Phenotypes in Group 2 Pulmonary Hypertension Using Bioactive Lipid Profiling. [PDF]

Circ Heart Fail
Garry JD, Brittain EL.
europepmc   +1 more source

Sotatercept as a Treatment for Pulmonary Hypertension Associated With Connective Tissue Disease and ILD. [PDF]

Open Respir Arch
Vargas-Ursúa F, Cruz-Utrilla A, Tenes A.   +2 more
europepmc   +1 more source